Clinical Drug Experience Knowledgebase

artemether (1 trial)

attenuated measles vaccine (rubeovax) (1 trial)

chloroquine (2 trials)

dihydroqinghaosu (2 trials)

dtap (2 trials)

human rotavirus, live attenuated (Rotarix) (12 trials)

inactivated influenza vaccine (5 trials)

inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)

lactobacillus rhamnosus (1 trial)

live attenuated chimeric japanese encephalitis vaccine (4 trials)

live attenuated sa 14-14-2 vaccine (2 trials)

lumefantrine (Coartem) (1 trial)

measles-rubella vaccine (1 trial)

mebendazole (vermox) (2 trials)

mmr (1 trial)

monovalent group c meningococcal vaccine (2 trials)

paromomycin (humatin) (3 trials)

piperaquinoline (4 trials)

poliovirus vaccine inactivated (2 trials)

primaquine (1 trial)

prp antigen (1 trial)

rotavirus vaccine, live, oral, pentavalent (rotateq) (2 trials)

sa-14-14-2 (1 trial)

tafenoquine succinate (arakoda) (1 trial)

yellow fever vaccine 17d strain (1 trial)

zn2+ (1 trial)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (3 trials)

amphotericin b (fungizone) (1 trial)

azithromycin (zithromax) (1 trial)

bivalent oral polio vaccine (bopv), type 1 and type 3 (4 trials)

brv-pv (1 trial)

cecolin (1 trial)

dipropyltryptamine (1 trial)

ditanrix (1 trial)

dpt-hepb-hib (1 trial)

eurartesim (1 trial)

fansidar (2 trials)

gsk 257049 (5 trials)

hepb-hib (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (3 trials)

inactivated rabies vaccine (Imovax) (2 trials)

ivacflu (3 trials)

ivermectin (stromectol) (1 trial)

live attenuated influenza virus vaccine (flumist) (4 trials)

live oral poliovirus type 1, 2 and 3 (3 trials)

matrix m1 (1 trial)

menacwy conjugate vaccine (2 trials)

nmcv-5 (1 trial)

orv 116e (1 trial)

phosphate-buffered saline (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (3 trials)

rotavin (1 trial)

synflorix (2 trials)

tv p2-vp8 (1 trial)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

abhayrab rabies vaccine (1 trial)

ace527 (1 trial)

ad26.cs.01 (1 trial)

ad35.cs.01 (2 trials)

as01b (6 trials)

as01e (1 trial)

as02a (2 trials)

aso2a (1 trial)

atovaquone (mepron) (2 trials)

bacille calmette-guerin (1 trial)

chad63 (1 trial)

cvd 1208s (3 trials)

dmlt (4 trials)

engerix-b (1 trial)

etec vaccine (3 trials)

falciparum malaria protein 11 (2 trials)

fmp1 (1 trial)

fmp2.1 (2 trials)

gsk 2189242a (1 trial)

gsk2245035 (1 trial)

haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

iowh032 (3 trials)

monovalent oral polio vaccines (mopv2) (2 trials)

mva me-trap (1 trial)

novel monovalent oral poliovirus vaccine type 2 (1 trial)

novel opv2 (1 trial)

p2vp8 (1 trial)

pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)

potassium alum (4 trials)

proguanil (2 trials)

pyrimethamine (daraprim) (1 trial)

rilpivirine (edurant) (1 trial)

rotavirus vaccine, live, oral, tetravalent (RotaShield) (1 trial)

rouvax (1 trial)

rsv-f subunit vaccine (1 trial)

rsv f vaccine (1 trial)

rts,s (2 trials)

rv3-bb (1 trial)

SB257049 (2 trials)

shigella flexneri 2a whole cell vaccine (1 trial)

sodium bicarbonate (1 trial)

s. pneumoniae whole cell vaccine (2 trials)

stamaril (1 trial)

sulfadoxine (1 trial)

tivantinib (1 trial)

tritanrix-hepb (2 trials)

trivalent p2-vp8 (1 trial)

trivalent p2vp8 subunit rotavirus vaccine (3 trials)

vaxigrip (1 trial)

vmp001 (1 trial)

as03 (1 trial)

detoxified shigella flexneri 2a artificial invasin complex (1 trial)

hev-sg-v (1 trial)

ic47 (1 trial)

influenza vaccine, recombinant hemagglutinin (1 trial)

ipv (1 trial)

mcv-5 (1 trial)

monovalent live attenuated pandemic influenza vaccine (2 trials)

monovalent oral polio vaccines (mopv1) (1 trial)

montanide isa 720 (1 trial)

msp-1 (fmp-1) with as02a (1 trial)

nmrc-m3v-ad-pfca (1 trial)

novel oral polio vaccine type 1 (nopv1) (1 trial)

novel oral polio vaccine type 3 (nopv3) (1 trial)

plasmodium falciparum chimeric prot. 2.9 (1 trial)

plasmodium falciparum sporozoite (1 trial)

recombinant influenza hemagglutinin (1 trial)

s. flexneri 2a 2457t (1 trial)

shigella flexneri 2a invaplex 50 (1 trial)

shigella sonnei strain 53g (1 trial)

streptococcus pneumoniae whole cell vaccine (1 trial)

tb31f (1 trial)

wrss1 (2 trials)

malarone (1 trial)

tenofovir (viread) (1 trial)